NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
Extended lab space for product development, customer demos, and training
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
Subscribe To Our Newsletter & Stay Updated
